메뉴 건너뛰기
The Lancet
Volumn 373, Issue 9670, 2009, Pages 1172-
Cytochrome P450 2C19 polymorphism and clopidogrel after MI
Author keywords

[No Author keywords available]
Indexed keywords

CANGRELOR; CLOPIDOGREL; CYTOCHROME P450 2C19; PRASUGREL; TICAGRELOR;
EID: 63349094415     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60681-4     Document Type: Letter
Times cited : (4)
References (3)
  • 1
    • 58249135635 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
    • Collet J.P., Hulot J.S., Pena A., et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 373 (2009) 309-317
    • (2009) Lancet , vol.373 , pp. 309-317
    • Collet, J.P.1    Hulot, J.S.2    Pena, A.3
  • 2
    • 17744376570 scopus 로고    scopus 로고
    • Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study
    • Patti G., Colonna G., Pasceri V., et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 111 (2005) 2099-2106
    • (2005) Circulation , vol.111 , pp. 2099-2106
    • Patti, G.1    Colonna, G.2    Pasceri, V.3
  • 3
    • 56949093392 scopus 로고    scopus 로고
    • Design and rationale of CURRENT-OASIS 7: a randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy
    • Mehta S.R., Bassand J.P., Chrolavicius S., et al. Design and rationale of CURRENT-OASIS 7: a randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. Am Heart J 156 (2008) 1080-1088
    • (2008) Am Heart J , vol.156 , pp. 1080-1088
    • Mehta, S.R.1    Bassand, J.P.2    Chrolavicius, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.